Skip to content

Resources

How participant safety is monitored

Learn about ethics review, visit checks, reporting symptoms, and why safeguards cannot eliminate every risk.

← All articles

General education, not personal medical advice. Study requirements and procedures vary. Discuss your care with your healthcare professional.

Several layers of oversight

Clinical research uses protections designed to reduce risks and support informed decisions. An institutional review board, or IRB, reviews research involving people with attention to their rights and welfare. The protocol describes safety procedures, and investigators are responsible for following the plan and evaluating participants. Depending on the study, an independent monitoring committee may also review accumulating information.

These protections do not make research risk-free. Some side effects are known in advance, while others may be unexpected. The consent discussion should describe foreseeable risks, uncertainties, and available alternatives. Ask which safeguards apply to the study you are considering rather than assuming every trial uses the same monitoring arrangements.

What the team may check

Monitoring may involve questions about symptoms and medicines, examinations, laboratory tests, or other protocol-specific assessments. A symptom or medical problem occurring during a study may be recorded as an adverse event even when its cause is not yet known. The team evaluates the information and reports it through the study's required channels. Findings may lead to additional checks, a change in participation, or a pause in the study.

Stay in contact between visits

Tell the team promptly about new symptoms, changes in medicines, emergency visits, or other health changes, even if you think they are unrelated. Keep the study contact information handy and ask how to reach the team outside regular hours. For a medical emergency, call 911 or seek emergency care; do not wait for a research appointment or a website reply. Tell the treating clinician that you are participating in a study.

Further reading

FDA

Questions about research?